Transurethral Plasmakinetic Resection of Prosate for Benign Prostatic Hyperplasia(274 Cases)
Qing-Ke Chen
Abstract
Qing-Ke Chen
Abstract
Objective To evaluate the validity of transurethral plasmakinetic resection of prosate for benign prostatic hyperplasia(BPH). Methods 274 cases of BPH were treated by TUPKRP and had been followed up at 3 months. Resuls The mean operative time was 54min. The mean postoperative hospital stay was 7 days. The peak flow rate of urine increased from 7.1mL/s to 20.7mL/s and the international prostate symptom score(IPSS)decreased from 26.3 to 7.0 at 3 months postoperatively(P0.05). Concluion TUPKRP is a safe and effective oprative method with less complications for the treatment of symptomatic BPH.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the validity of transurethral plasmakinetic resection of prosate for benign prostatic hyperplasia(BPH). Methods 274 cases of BPH were treated by TUPKRP and had been followed up at 3 months. Resuls The mean operative time was 54min. The mean postoperative hospital stay was 7 days. The peak flow rate of urine increased from 7.1mL/s to 20.7mL/s and the international prostate symptom score(IPSS)decreased from 26.3 to 7.0 at 3 months postoperatively(P0.05). Concluion TUPKRP is a safe and effective oprative method with less complications for the treatment of symptomatic BPH.
Key concepts: Medicine, Hyperplasia, Resection, Urology, Prostate, Urine flow rate, International Prostate Symptom Score, Urinary flow